Sources | Names Used |
---|---|
CCLE, GRAY, UHNBreast | AZD6244 |
GDSC1000, CTRPv2 | selumetinib |
FIMM | Selumetinib |
PharmacoGx | AZD6244 |
Database | Identifier |
---|---|
Smiles: | CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO |
Inchikey: | CYOHGALHFOKKQC-UHFFFAOYSA-N |
Pubchem: | 10127622 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ACTN1 | CCLE | pan-cancer | AAC | 0.3 | 5e-08 |
mRNA | CD300LF | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | MCUB | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-08 |
mRNA | TIMELESS | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-08 |
mRNA | CD27 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
mRNA | PIWIL4 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
mRNA | FUT4 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
mRNA | LAD1 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-08 |
mRNA | HCFC2 | CTRPv2 | pan-cancer | AAC | -0.21 | 7e-08 |
mRNA | BORCS8-MEF2B | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-08 |